缺血性卒中溶栓治疗的研究进展  

Progress in the treatment of ischemic stroke thrombolysis

作　　者：袁利和[1] 和姬苓[2] 黄维星[1] 王世霞[1] 

机构地区：[1]内蒙古医科大学第三附属医院神经内科,内蒙古包头014010 [2]包头医学院第一附属医院神经内科

出　　处：《疾病监测与控制》2014年第3期157-159,共3页Journal of Diseases Monitor and Control

摘　　要：研究表明溶栓治疗是有效和安全的,但溶栓药物的选择与剂量、溶栓治疗时间窗、适应证、溶栓途径、合并用药的利弊、溶栓后并发症等问题仍是面前研究的热点,本研究对此方面的研究现状及进展进行综述。Studies have shown that thrombolytic therapy is effective and safe, but the choice and dose of thrombolytic drugs, thrombolytic therapy time window, indications, thrombolytic way, the pros and cons of combination therapy, complications after thrombolysis is still a hot topic at present. The present research situation and progress in this regard are reviewed in this article.

关 键 词：缺血性卒中 溶栓治疗 重组组织型纤溶酶原激活剂(rt—PA) 

分 类 号：R743.33[医药卫生—神经病学与精神病学]